Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 216-032-5 | CAS number: 1477-55-0
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Genetic toxicity: in vivo
Administrative data
- Endpoint:
- in vivo mammalian somatic cell study: cytogenicity / erythrocyte micronucleus
- Remarks:
- Type of genotoxicity: chromosome aberration
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 1989-07-10 to 1989-08-07
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: GLP guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 989
- Report date:
- 1989
Materials and methods
Test guidelineopen allclose all
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 474 (Mammalian Erythrocyte Micronucleus Test)
- Deviations:
- yes
- Remarks:
- feed was withheld overnight prior to dosing until approximately 8-9 hours after administration of the test substance, instead of 3-4 hours as stated in the protocol
- Qualifier:
- according to guideline
- Guideline:
- EPA OTS 798.5395 (In Vivo Mammalian Cytogenics Tests: Erythrocyte Micronucleus Assay)
- Deviations:
- yes
- Remarks:
- see above
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.12 (Mutagenicity - In Vivo Mammalian Erythrocyte Micronucleus Test)
- Deviations:
- yes
- Remarks:
- see above
- GLP compliance:
- yes
- Type of assay:
- micronucleus assay
Test material
- Reference substance name:
- m-phenylenebis(methylamine)
- EC Number:
- 216-032-5
- EC Name:
- m-phenylenebis(methylamine)
- Cas Number:
- 1477-55-0
- Molecular formula:
- C8H12N2
- IUPAC Name:
- 1-[3-(aminomethyl)phenyl]methanamine
- Test material form:
- liquid
- Details on test material:
- - Name of test material (as cited in study report): Metaxylenediamine
- Physical state: Clear liquid
- Stability of test article: More than 6 months when under nitrogen atmosphere
- Stable for at least 4 hours in vehicles: Stable in water during 24 hours but precipitate in a carbon dioxide atmosphere. Therefore, the use of carbon dioxide during exposure time was avoided.
- Storage condition of test material: In the original container under nitrogen at room temperature in the dark
- Safety precautions: Gloves, goggles and face mask were considered sufficient to ensure personal health and safety
Constituent 1
Test animals
- Species:
- mouse
- Strain:
- other: Swiss CD-1 (SPF quality)
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Swiss mice, CD-1 (SPF quality)
- Source: Charles River Wiga GmbH, Sulzfeld, FRG
- Age at study initiation: Approximately 8 weeks
- Date of arrival of animals: 04 July 1989
- Identification: By unique cage number and a mark on the tail
- Assigned to test groups randomly: Yes, allocated to treatment groups as the animals came to hand from delivery boxes
- Weight at study initiation: 20-26 g (females), 26-34 g (males)
- Fasting period before study: Feed was withheld overnight prior to dosing until approximately 8-9 hours after administration of the test subtance.
- Housing: In groups of 5 per sex in polycarbonate cages.
- Bedding: Purified sawdust (Woody Clean, Broekmann Institute, Someren, The Netherlands)
- Diet: Standard Laboratory animal diet, RMH-B, pellet diameter 10 mm, Hope Farms, Woerden, The Netherlands. The feed was analysed for contaminants by the manufacturer.
- Water: Tap water, ad libitum. Results of chemical and contaminant analyses were archived.
- Acclimation period: At least 6 days under laboratory conditions
ENVIRONMENTAL CONDITIONS
- Temperature: 21 ± 3 degrees Centrigrade
- Humidity: 40-70 %
- Air changes: 7.5 per hour
- Photoperiod: 12 hours artificial fluorescent light and 12 hours darkness
Administration / exposure
- Route of administration:
- other: intubation
- Vehicle:
- - Milli-RO water
- Details on exposure:
- - Method: The test substance was administered by oral intubation.
- Rationale: The route of administration was selected taking into account the possible route of human exposure during manufacture, handling and us
- Dosing volume: 10 mL/kg body weight - Duration of treatment / exposure:
- Single dose
- Frequency of treatment:
- Once
- Post exposure period:
- - Test animals were sacrificed at 24, 48 and 72 hours after dosing.
- Positive controls were sacrificed at 48 hours after dosing
Doses / concentrations
- Remarks:
- Doses / Concentrations:
750 mg/kg body weight
Basis:
- No. of animals per sex per dose:
- 5 males and 5 females
- Control animals:
- yes, concurrent vehicle
- Positive control(s):
- - Cyclophosphamide (CP; CAS number 50-18-0 obtained from Endoxan, Astra-Werke, F.R.G) at 50 mg/kg body weight dissolved in 0.9 % sodium chloride (Merck) in Milli-RO water
- The route and frequency of administration and the volume administered were consistent with those of the test article.
- Solutions were prepared on the day of administration
- The stability of CP at room temperature is good. At 20 degrees Centigrade only 1 % of CP is hydrolysed per day in aqueous solution.
Examinations
- Tissues and cell types examined:
- Bone marrow
- Details of tissue and slide preparation:
- After the animals were sacrificed, both femurs were removed and freed of blood and muscles. Both ends of the bone were shortened until a small opening to the marrow canal became visible. The bone was flushed with approximately 2 mL of foetal calf serum. The cell suspension was collected and centrifuged at 1000 rpm (approximately 100 g) for 5 minutes.
- Evaluation criteria:
- A test substance is considered positive in the micronucleus test if it induced a biologically as well as a statistically significant increase in the frequency of micronuclei (at any dose or sampling time) in the combined data for both sexes or in the data for male or female groups separately.
A test substance is considered negative in the micronucleus test if none of the testing concentrations or sampling times showed a statistically significant increase in the incidence of micronuclei neither in the combined data for both sexes nor in the data for male or female groups alone. - Statistics:
- Wilcoxon Rank Sum Test; two sided test at p < 0.05
Results and discussion
Test results
- Genotoxicity:
- negative
- Additional information on results:
- Pilot study/dose selection
The animals of Group 1 did not show any signs of reaction to treatment. Animals of Group 2 and 3 recovered from the lethargy observed immediately post-dosing. In Group 4, three animals died within 48 hours post-dosing (one male, two females). In Group 5, all animals died within 24 hours post-dosing and in Group 6, all animals died within 4 hours post-dosing.
Based on the results of the pilot study, 750 mg/kg body weight was selected as an appropriate dose for the micronucleus test.
Main study
The mean bodyweights per group recorded immediately prior to dosing are presented in the Table 1 (attached).
The mean number of micronuclei per group and the mean ratio of polychromatic to normochromatics erythrocytes are presented in Table 2 (attached).
No increase in the frequency of micronuclei was observed.
Two male mice died between 2 and 3 days after dosing (one from Group E and one from Group F). The ratio of polychromatic/normochromatic erythrocytes does not evidence any toxic effect of the test substance on erythropoiesis.
The incidence of micronuclei in the control animals was found to be in the range of historical data (0.66 ± 0.93; mean ± standard deviation, N = 910).
The groups that were treated with with cyclophosphamide showed a decrease in the ratio of polychromatic to normochromatic erythrocytes, which reflects a toxic effect of this compound on erythropoiesis.
Any other information on results incl. tables
Individual data are described in tabular form below. The mean number of micronuclei scored in the test substance-treated groups was compared with the corresponding control groups.
Micronucleus test: individual data
Group A-G males; oral dosing of metaxylenediamine
Group |
Animal number |
Number of micronuclei per 1000 polychromatic erythrocytes |
Ratio polychromatic / normochromatic erythrocytes |
A |
2 |
0 |
0.86 |
A |
4 |
0 |
0.93 |
A |
6 |
0 |
1.00 |
A |
8 |
1 |
0.86 |
A |
10 |
0 |
0.89 |
|
|
|
|
B |
12 |
0 |
1.07 |
B |
14 |
0 |
0.77 |
B |
16 |
0 |
1.02 |
B |
18 |
0 |
1.02 |
B |
20 |
1 |
0.92 |
|
|
|
|
C |
22 |
0 |
1.15 |
C |
24 |
0 |
0.92 |
C |
26 |
1 |
1.05 |
C |
28 |
0 |
0.98 |
C |
30 |
1 |
1.01 |
|
|
|
|
D |
72 |
0 |
0.88 |
D |
74 |
0 |
0.96 |
D |
76 |
0 |
0.90 |
D |
78 |
1 |
1.08 |
D |
80 |
0 |
0.87 |
|
|
|
|
E |
82 |
2 |
1.01 |
E |
84 |
0 |
0.84 |
E |
86 |
1 |
0.95 |
E |
88 |
2 |
0.98 |
E |
90* |
- |
- |
|
|
|
|
F |
92* |
- |
- |
F |
94 |
0 |
0.95 |
F |
96 |
0 |
0.90 |
F |
98 |
0 |
0.88 |
F |
100 |
0 |
0.89 |
|
|
|
|
G |
62 |
12 |
0.30 |
G |
64 |
6 |
0.27 |
G |
66 |
8 |
0.25 |
G |
68 |
9 |
0.36 |
G |
70 |
10 |
0.34 |
|
|
|
|
* Animal died after dosing.
Micronucleus test: individual data
Group A-G females; oral dosing of metaxylenediamine
Group |
Animal number |
Number of micronuclei per 1000 polychromatic erythrocytes |
Ratio polychromatic / normochromatic erythrocytes |
A |
1 |
0 |
0.90 |
A |
3 |
1 |
0.96 |
A |
5 |
0 |
1.03 |
A |
7 |
0 |
0.95 |
A |
9 |
0 |
0.96 |
|
|
|
|
B |
11 |
1 |
1.14 |
B |
13 |
1 |
0.94 |
B |
15 |
0 |
0.89 |
B |
17 |
0 |
1.00 |
B |
19 |
0 |
0.98 |
|
|
|
|
C |
21 |
0 |
1.09 |
C |
23 |
0 |
1.10 |
C |
25 |
0 |
1.08 |
C |
27 |
1 |
0.97 |
C |
29 |
0 |
0.94 |
|
|
|
|
D |
71 |
1 |
1.00 |
D |
73 |
0 |
0.80 |
D |
75 |
0 |
0.88 |
D |
77 |
0 |
0.87 |
D |
79 |
1 |
0.76 |
|
|
|
|
E |
81 |
0 |
0.91 |
E |
83 |
2 |
0.95 |
E |
85 |
0 |
0.95 |
E |
87 |
1 |
0.90 |
E |
89 |
1 |
0.79 |
|
|
|
|
F |
91 |
1 |
1.13 |
F |
93 |
1 |
1.04 |
F |
95 |
0 |
0.99 |
F |
97 |
0 |
1.04 |
F |
99 |
0 |
0.89 |
|
|
|
|
G |
61 |
7 |
0.47 |
G |
63 |
11 |
0.35 |
G |
65 |
11 |
0.36 |
G |
67 |
7 |
0.47 |
G |
69 |
15 |
0.31 |
The positive control substance induced in both sexes a statistically significant increase in the number of micronuclei:
Wilcoxon rank-sum test
Number of micronuclei per 1000 polychromatic erythrocytes; treatment/control comparison
Group |
Treatment |
Dose mg/kg body weight |
Sex |
p-value (two-sided) |
Decision at 95 % confidence level |
G |
CP |
50 |
Males |
0.01 |
Significant |
G |
CP |
50 |
Females |
0.01 |
Significant |
Applicant's summary and conclusion
- Conclusions:
- Interpretation of results (migrated information): negative
It is concluded that the test is valid and that metaxylenediamine can be considered as not mutagenic in the micronucleus test under the experimental conditions decribed.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.